Diabetes in COVID-19: Management
The COVID-19 (Corona Virus Disease-19) has become the most critical health problem worldwide. It was
first started from Wuhan, China and now it has affected more than 230 countries and millions of people.
The diabetic patients with uncontrolled glycemic state for long term can result in many microvascular and
macrovascular complications. Hence they are most commonly affected individuals during COVID-19. In
this review we have briefed about the impact of COVID-19 in diabetes, the different pathophysioloy and
management of diabetes in this phase.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions